Ladies and gentlemen, thank you for standing by, and welcome to the Tronox Holdings plc Q4 2019 Earnings Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] Please be advised that today’s conference is being recorded. [Operator Instructions] I would now like to introduce your host for today's conference call, Mr. Brennan Arndt, Senior Vice President of Investor Relations. You may begin, sir.

Thanks, Kevin, and welcome everyone to our fourth quarter and full year 2019 conference call and webcast. On our call today are Jeff Quinn, Chairman and Chief Executive Officer; Jean-Francois Turgeon, Chief Operating Officer; John Romano, Chief Commercial and Strategy Officer; Tim Carlson, Chief Financial Officer; and Jennifer Guenther, incoming Vice President of Investor Relations. We will be using slides as we move through today's call. Those of you listening by Internet broadcast through our website should already have them. For those listening by telephone, if you haven't already done so, you can access them on our website at tronox.com. Moving to Slide 2, a reminder that comments made on this call, and information provided in our presentation and on our website include certain statements that are forward-looking and subject to various risks and uncertainties, including, but not limited to the specific factors summarized in our SEC filings. This information represents our best judgment based on today's information. However, actual results may vary based on these risks and uncertainties. The company undertakes no obligation to update or revise any forward-looking statements. During the conference call, we will refer to certain non-U.S. GAAP financial terms that we use in the management of our business and believe are useful to investors when evaluating the company's performance. Reconciliations to their nearest U.S. GAAP terms are provided in our earnings release and in the appendix of this presentation. As you saw in our earnings release, we’ve provided our results on both a reported basis and a pro forma basis to assist in our discussion of fourth quarter 2019 performance, compared to the fourth quarter of 2018 and full-year 2019 performance, compared to the full-year 2018. Our primary focus today on those comparisons will be on the pro forma results to enhance your understanding of the underlying trends on our business performance, and in our markets. In the appendix of our earnings release and this presentation are a statement of operations and adjusted EPS and adjusted EBITDA reconciliations, all on a pro forma basis for the fourth quarters of 2019 and 2018, and the full-year 2019 and 2018. Moving to Slide 3, it's now my pleasure to turn the call over to Jeff Quinn. Jeff?

Thanks, Brennan. Good morning, everyone, and thank you for joining us today. Before diving into the financials, I want to take just a brief moment to reflect on last year on 2019. 2019 marked a transformative year for Tronox with the close of the crystal acquisition through which we formed the world's largest vertically integrated TiO2 producer. Now, with nine pigment plants and eight mineral sands facilities across six continents, we operate with an unmatched global footprint. That footprint allows us to continue to grow with our customers as they grow anywhere in the world and continue to benefit from our alignment with customers who are growing faster than the overall market. The success of our bespoke win-win margin stability initiative has enhanced the stability of our top line relative to historic industry patterns. This stability is reflected in our global average TiO2 selling price, which remained essentially level on a sequential basis across 2019. We over delivered on our 2019 synergy target and are increasing our synergy targets for 2020 through 2022, as we discover additional and increased value-added opportunities in the new Tronox, which I’ll cover in more detail in a couple of slides. We returned approximately $315 million to shareholders in 2019 through share repurchases and our regular dividend and made a $100 million discretionary debt payment. We maintained a relentless focus on safety and enhanced our commitment to sustainability, including the appointment of our Chief Sustainability Officer to manage our ESG initiatives. Of course, none of this would be possible without our employees. Investing in and developing our people is a key focus area of mine. To this end, we’ve renewed our employee development initiatives, including improving diversity and inclusion. 2019 was an accomplished year of Tronox, despite a challenging macroeconomic environment. We believe we are…

Thanks, Jeff and good morning. Moving to Slide 6, first the year-on-year comparison, which as Brennan said focuses on the pro forma numbers to give you a clear understanding of our commercial performance and the trends in our markets. Revenue of $693 million was 5% lower than a year ago with TiO2 pigment sales of 544 million were 1% lower. Sales volumes increased 3%, while selling prices were 4% lower on a local currency basis. On a U.S. dollar basis selling prices were 5% lower as FX translation; primarily the euro was a $6 million headwind on revenue. The sales volume increase reflects the continued strength in North America offset by the completion of destocking in Europe and Asia. Inventories across regions and across the value chain largely appeared to be at normal levels today. The reason for the lower year-on-year average TiO2 selling price is once again primarily our prior year issue due to Cristal's commercial approach in 2018. We will see this carry-forward to the first quarter as price harmonization was completed in Q2, shortly after we closed the acquisition as we’ve discussed. As you will see in the sequential comparison, our global average selling prices once again have remained essentially stable, as they did in each sequential comparison in 2019. Moving to Zircon, sales of $71 million were 34% lower than a year ago. Sales volumes were 29% lower when compared to Q4 2018, which was one of our strongest quarters on record, as well as softer market conditions, primarily in China with the continued impacts of the trade war environmental regulations and generally slower growth. Selling price prices were 6% lower, primarily due to increased competitive activity from lower quality Zircon products, which had a negative impact on product mix and price. However, that decline was…

Thanks John and good morning everyone. Moving to Slide 9, let’s first review the year-on-year pro forma adjusted EBITDA comparison. Adjusted EBITDA of $156 million was 28% lower than pro forma adjusted EBITDA of the year ago quarter. As John discussed, lower TiO2 selling price related to legacy Cristal commercial approach in 2018 and lower Zircon volume were the primary commercial driver. Additionally, we were met with higher production costs, including general inflation, higher ore cost and normal seasonal maintenance in our integrated operation, partially offsetting this factor was favorable foreign exchange on costs, primarily the South African rand and the Australian dollar. In addition, synergy contributed an improvement to EBITDA of $25 million. We are very pleased with the synergy delivery to date. As Jeff outlined, we continue to find additional value add opportunity from the combination driving the increased target we’ve previously mentioned, and the benefits are coming from true cost saving [growing an] opportunity to use feedstock across our network to benefit our operation, and realize significant cost saving in our supply chain. In 2020, we will continue to realize incremental saving in these areas and start to see additional operational synergy such as improving the cost position and quality of our product produced at Yanbu, utilizing best practice across our operation and reducing costs at legacy Cristal plant such as Brazil. On the last point, we are already seeing cost reduction out of Brazil this year and are excited about the additional opportunity the team has identified, which we will start to realize in the reminder of 2020. Delivering the synergy is only one part of our operational excellence program. Our global team is relentlessly driving to lower our costs per ton across all our operations increasing product quality, optimizing our global footprint, and most importantly…

Thanks JF. Moving to Slide 10 and starting with our balance sheet. We ended the year with total debt of $3 billion and net debt of 2.7 billion. Given our strong free cash flow, we made $100 million discretionary debt repayment on our term loan in December. Our liquidity was $648 million comprised of cash and cash equivalents and 302 million and 346 million available under revolving credit agreements. In addition, we ended the year with $9 million restricted cash. Our net leverage was four times on a pro forma trailing 12-month basis. We continue to target a net leverage ratio of 2 to 3 times, which we are targeting to achieve by the end of 2021 consistent with the guidance given at Investor Day. Our capital allocation policy remains unchanged. We continue to prioritize disciplined capital spending on high return projects and on deleveraging. Capital expenditures in the fourth quarter were $58 million, compared to our depreciation and depreciation and amortization expense of 75 million. In 2019, our cash capital expenditures were $198 million, slightly below our guided range of 200 million to 215 million. Approximately one-third of our capital was focused on increasing our EBITDA per ton and the remaining two-thirds was on maintenance, ESG, and other projects. Our depreciation and amortization expense was 280 million in-line with our guided range of 282 to 290, both figures are recorded on an as reported basis. Regarding returning capital to shareholders, we returned $315 million in 2019 for the repurchase of approximately 21.5 million shares in our regular dividend payments. As Jeff mentioned, we will be increasing our quarterly dividend by 56%, which results in an annual dividend of $0.28 per share, reflecting our confidence in the consistently strong cash generation capability of our vertically integrated business mile across cycles. Regarding our 2020 outlook, while global macroeconomic conditions remain uncertain and considering the near-term softness in the Zircon market, we remain confident in our ability to deliver the commitments within our control. For the full-year 2020, we expect to achieve revenue of $3 billion to $3.3 billion, adjusted EBITDA of $700 million to $800 million, adjusted diluted EPS of $0.55 to $1.10, free cash flow of over 200 million, capital expenditures of 260 million to 290 million, and we’re targeting our net leverage at three times by the end of 2021. Before returning the call back to Jeff, I’d like to take a moment to thank our global finance team for their dedication and efforts to [indiscernible] crystal acquisition. We're still finalizing our purchase accounting analysis and disclosures and will take advantage of the 15 calendar day extension to file our 10-K, which will be on or before March 16. With that, I’d like to turn the call back over to Jeff to add additional color to our outlook in key focus areas for 2020. Jeff?

Thanks Tim. The numbers that Tim just walked you through represent our current outlook balancing global macroeconomic uncertainty and near-term softness in Zircon with the beginning of an uptick in the TiO2 sector and our confidence in our ability to deliver our increased synergy targets. At the midpoint, our guidance range for adjusted EBITDA represents a 10% increase over 2019 pro forma results, reflecting the macro conditions and market dynamics we face coming out of the back half of 2019 and our expectations for an uptick in the back half of 2020. Just as a reminder, $100 a ton increase in average pigment selling prices has a $20 million to $25 million EBITDA impact per quarter and a $100 per ton increase in Zircon prices has an approximately $4 million to $5 million EBITDA impact per quarter. So, there is significant leverage in our system to an improved pricing environment. Our guidance also reflects an estimated $30 million EBITDA impact of the ongoing furnace realign at KZN, which will take one of our five furnaces off-line for approximately 95 days. The financial impact includes the expense of the realign and the fixed cost impacts in the feedstock pigment business. Advancing this reline to this quarter, will have a positive effect on the availability of feedstocks in future quarters as feedstocks continue to tighten and pigment prices will likely increase. Our guidance also reflects what we're seeing in terms of cost inflation and the current type feedstock market, while due to our vertical integration the impact of rising feedstocks on us is [new to] compare to our peers it does have some impact. Free cash flow of over $200 million reflects our plans to invest $275 million in high return capital projects during the upcoming year through our disciplined capital allocation…

[Operator Instructions] Our first question comes from Frank Mitsch with Fermium Research. Frank your line is open; you can ask your question. Frank, if your line is muted could you please unmute it.

Hi guys, it’s Suzanne for Frank. The first question I had on the synergy increases, could you guys just elaborate more on and within which areas you guys are seeing those increases?

Look, it’s basically some of the work that we did last year that will start to generate on the best practice transfer. So, obviously combining the chlorination knowhow of legacy Tronox with legacy Cristal there was some trick if I could use that term from operator of one business that had to be transferred to the operator of the order of business and those takes time, and obviously the synergy on supply chain, the synergy on moving our additional feedstock to the new asset that we quickly react and we will continue to get more out of those quick reactions, but the best practice transfer is really where we will start to use the advantage this year.

It’s Tim and the follow on that. When we lay our targets for synergies, we actually risk-adjusted them and as we get into the activities we’re more and more comfortable in terms of where we’re ending up, in terms of cost reductions across the system whether it be SG&A in operations in very, very little on volume.

Okay. Thank you for that. And then as a follow-up, I know you guys touched on the early supply demand you guys – the impacts you guys are seeing from the coronavirus, but could you guys just elaborate a bit more on industry supply tightening in the region and what you guys are seeing on the demand side as well?

Yes. This is John Romano. So, from the standpoint of supply demand and inventory, as I mentioned earlier, inventory we believe is where it should be for this time of the year. So, I’d say at seasonal norms, and the uptick that we talked about as a result of COVID-19 was just a short-term impact. We saw volumes picking up as we entered the first quarter long before, at least a month before COVID actually took hold. So, what we’re seeing is in effect as I mentioned on slide, I think it was Slide number 8 where we saw the recovery from a 17 month downturn, we're starting to see a good indicator that demand has returned and supply and demand is in a position where as Jeff mentioned will likely to start working towards looking at upsides on pricing as we enter the second half of the year.

But it is clearly what we're seeing from customer enquiries and just enter totally from stories on the ground, this is impacted Chinese supply.

Got it. Thank you, guys.

Our next question comes from Duffy Fischer with Barclays.

Good morning, fellows. First question just on Zircon because it’s a market at least I don’t spend as much time on is TiO2, you know volume down big, price has hung in well like on like, so can you talk about when you look at your footprint because you talked about mix shift being a little bit negative, but just like-on-like how much of a price is down from the peak over the last of years and then if you did like a 10 year look back where are prices for your products today versus maybe a normalized number over the last 10 years?

If you look at – the last 10 years includes a spike, which is not I would say something that will be duplicated where prices were in the 2,400 range. So, the 6% down is really from about where we peaked somewhere in the [15, 16 range] and when we look at how we’re moving into the first quarter of 2020, the guidance we provided had some additional price erosion factored into the first quarter. So from a demand perspective, first half and second half are going to be kind of flipped from where it was last year. So it’s a kind of a tail of two years where the first year will continue to be a bit slower and as we move into the second half of the year we’re planning for a recovery.

Okay. And then, if you hit the midpoint of your CapEx this year, the [$275 million] roughly how would that break down just regular maintenance versus efficiency projects versus kind of true growth in volume?

Hi, Duffy it’s Tim. Of the $275 million, our maintenance and safety capital ranges anywhere from $100 to $125 million. We've got some capital in the plant for continuing cost reduction in terms of driving EBITDA per ton and then we've got some additional capital in our plan for our mine extension that we will be doing in Australia associated with leveraging our vertical integration benefits.

Great. Thank you, guys.

Thank you.

Our next question comes from John McNulty with BMO Capital Markets.

Yes morning. Thanks for taking my question. So, with regard to the, what looks like an early uptick in the supply demand balance, I guess how would you, like what are you seeing in terms of demand for some of the margin stability initiatives that you’ve put out there, have you seen a notable increase yet in customers looking to lock in or is that something that’s may be [more onto come]?

Yes, this is John Romano. So, from margin stability, again it played a significant role I think in our profitability in the last 18 months and with regards to customer’s interest in that program it continues to accelerate and when we think about cross segments regions it’s not just North America where we’re getting traction on that. It’s also in the other regions of the world, including paper plastic and coatings.

Got it. And then with regard to the free cash flow guidance the 200 million or 200 million plus that you're looking for in 2020, so assuming that you can hit that even at the bottom of your range, I guess in terms of EBITDA range if you comment at the high-end it as simple as you're going to come in close to a $300 million number or are the levers that you’re pulling in that kind of downside scenario that you wouldn't necessarily pull as you’re looking towards the higher end of that range, like how should we think about the cash flow variance?

Hi John, it’s Tim. Excellent question. There are a couple levers that we can pull but you are spot on in terms of if we come in at the high-end of that range a little bit directly, a direct impact in terms of increasing our free cash flow. We continue to work our balance sheet in terms of optimizing working capital. We do have a $50 million to $70 million working capital burn in that cash flow forecast, we hope to minimize that, but at the same point in time if there are opportunities where we see incremental spend that we can do to increase EBITDA per ton by taking cost out of our system remain increased little bit of capital spend in that regard.

Great. Thanks very much for the color.

Thanks John.

Our next question comes from Jim Sheehan with SunTrust Robinson.

Good morning. This is Pete Osterland on for Jim. Can you comment on the pricing environment for titanium-based ores and the magnitude of cost inflation you expect in 20 2040 for the ores that you do not?

So, Pete it’s JF. We are in 2020 75% vertically integrated. So, we think that we’re the best position versus our competitor for digesting those price increase. Look, if you look at different products that we use in our pigment plant, rutile is the one that has increased the most and it’s more than a double-digit increase that we have experienced on the price of rutile, because look it’s a product that is in high demand and it’s rare. I mean there’s not that much available in the world. Slag and SR is also very tight as a market and we have seen significant price increase in that front. And even ilmenite has recently as what we have seen out of China, the ilmenite price has jumped because of the COVID-19 and look it’s obviously positive for the whole TiO2 side of the business because margin specifically in China are very tight and as soon as their feedstock increase, TiO2 has to increase to match those. So, that would be my comment on feedstock.

Thank you. And then you spoke about deleveraging as a priority, but given where shares are currently valued, would you consider share repurchases, as well as the use of cash during 2020?

Yes, I mean, we always allocate sort of between those three priorities we’ve talked about, but deleveraging remains first and foremost among those. So, we will look aggressively at that and the high return projects we have and then maybe look at share repurchases, but I would think that in those priorities are sort of in that relative order.

And [Jim], it’s Tim, as a follow-on, we do have some limitations on share repurchase as a result of our NOL limitations.

Thank you.

Our next question comes from Jeff Zekauskas with JPMorgan.

Thanks very much. Since you are a titanium dioxide producer in China, are your prices going up already given the raw material inflation, do you want to sell to the domestic market, do you want to sell to the export market, have you seen the word from the point of view of your China operation?

Hi Jeff, it’s John. So, on both those questions, as far as how we're going to sell and how we’ve been looking at selling the Chinese material out of our plant in Fuzhou, we’ve been looking to optimizing that margin whether we sell in China or maybe take some of that product and move it to higher margin areas. With respect to pricing in China, we have seen prices move up and that was before COVID-19 actually took hold. So, we started raising that price in China early in January and have gone through an implementation process. So, we’re seeing pricing move. No to JF's point a few minutes ago, this whole [indiscernible] feedstock supply constraint is having a significant impact on company’s ability to actually procure or at a price that’s not inflated significantly and with lower percentages of TiO2 it’s buy 2 tons to get a ton of pigment. So, for a variety of reasons I think we’re optimistic around where pricing is going for China.

Okay. And then for my follow-up on Slide 9 you have your EBITDA purchase, and on the left hand part of the Slide you indicate that there were 45 million in higher production costs year-over-year, I was wondering why that was the case? And then on the right-hand side of the slide, it says there was an absence of integration margin benefit of 20 million sequentially in the fourth quarter versus the third quarter and I was wondering what that was, can you clarify those two red downward bars?

Sure. Jeff I will start. You have to realize that in Q4 2018 the business was owned by someone who was about to sell the business and I’d say that in legacy Cristal plant, maintenance was not at the level that it should have been and Q4 is always the quarter where we try to do more maintenance and put the asset in a good condition to operate. As we took control, Q4 was the quarter where we had time to assess what needed to be done and we probably did a little bit more than less on that front and that’s obviously come at a cost and that’s an increase in cost, and that I’d say one of the important component. Tim, you want to add.

Jeff as it relates to the absence of the integration margin benefits, just as a reminder in Q3, Q4 of 2018 we made a decision to stop selling feedstocks to the open market and as a result of putting that feedstock on our balance sheet and not selling it to the open market, all of the profit in our South African operation and our Australian feedstock operation that we would normally have realized by selling it to third parties, when we sold it internally to our pigment plants. We actually had to capture that incremental profit on our balance sheet and we put about $40 million to $50 million of profit on our balance sheet in Q4 and Q1, and you probably remember if you look back at those calls it was actually quite a bit of headwind and then we realized in Q2 and Q3 of this year as we sold, as we manufactured the pigment and sold the pigment with that ore in it, we realized the profit from that product and as a result it’s really just a shift of timing of margin benefit from Q4, Q1 to Q2 and Q3.

And that’s for – both the ends are one-time thing that we shouldn't see as we go forward.

I understand what you said to me, just now you're in inventory costs in the fourth quarter were higher than they were in the third quarter?

No, not exactly Jeff. What happened was all of the profit that we would normally have realized in Q4 and Q1 of last year as a result of selling to third parties we sold internally. So that profit actually went on to the balance sheet and that lower cost inventory flowed through just from a timing standpoint from Q4, Q1 into Q2 and Q3. So, as Jeff mentioned it was probably just a one-time benefit that shipped to profit between those four quarters.

Okay, great. Thank you so much.

The next question comes from Vincent Andrews with Morgan Stanley.

Hi, this is actually Steve on for Vincent. Just wanted to ask a question on Zircon, can you help us think about how much EBITDA was actually generated from Zircon in 2019 and what’s kind of assumed at the high-end and the low-end of your guidance from 2020?

So, we haven't disclosed publicly EBITDA from Zircon, but zircon does generate higher contribution margins than TiO2, you know, north of 50%, so any degradation in terms of Zircon volume does have a significant impact on our overall EBITDA.

And then maybe just a quick follow-up on the working capital because I thought and maybe I misheard that, you guys are going to have a headwind in 2020, but it looks like there is a pretty significant tailwind in 2019, so was there a timing benefit in 2019 that’s reversing in 2020, or could you just help us bridge the two pieces?

Yes. So, it’s really mix of working capital. The team did a phenomenal job at – in the fourth quarter as it relates to DSO and DPO. Where we’re getting hurt a bit in 2020 is around the inventory levels. You know inventory levels are building a bit just given the recovery that John talked about. We see them reversing and declining again in Q3 and Q4, but obviously, any acceleration in terms of that recovery would reduce our inventory balances and drive significantly more free cash.

It's normal for us to build inventory in Q1 and Q4.

Thanks guys.

Thanks [Steve].

Our next question comes from Josh Spector with UBS.

Good morning. This is [indiscernible] on for Josh. You mentioned you’re seeing early uptick in demand in Europe, can you just provide a little bit more color what end-markets you're seeing this uptick? And specifically which markets are the strongest? And then, you also talked about back integration, can you just remind us when your feedstock contracts roll off? Thanks.

Yes. So, on the uptick in Europe, I’d say it’s largely across all segments. it's not focused in any one particular area, and as we exited the 2019, we had started to see the effects of the destocking being complete and the order books started to improve moving into January, and so, we’ve got pretty good visibility. As I’ve mentioned before, our order book is a good indicator on what we’re seeing, and you know, the numbers that we’re looking at right now that go out past the first quarter would support this uptick that we’re referring to and it's not – most of that is not on the back of, you know, COVID-19.

And, Matt, on the [bank integration], we still have contract that we have to honor in 2020, but by 2021 we’ll be out of all our commitment.

That’s helpful. Thank you so much.

Our next question comes from Roger Spitz with Bank of America.

Thanks very much. Would you be interested in giving the EBITDA guidance for the first quarter of 2020?

No, Roger. I don’t think that’s something that we’re prepared to do. I think we have a lot of moving dynamics in the marketplace right now, and as we’ve said, we’re cautiously optimistic about what we see as what we believe is an uptick. And then, we have, obviously, offsetting that the one-time issue with the furnace reline at KZN. So, you know, we look at this business over the longer term, longer period and really don't think it's appropriate to start segregating into the quarter-by-quarter.

That’s fine. And can you say what the cash expenses to obtain this 2020 synergies that are not in CapEx that are instead, you know, otherwise in your free cash flow guidance?

It’s going to be minimal $5 million or $6 million.

Okay. And is, you know the Chinese tile industry is back to work or they, you know, can't get to work because of coronavirus, can you comment on the demand on Chinese tile?

Yes. So look, the majority I would say, are customers, and again, there our customers’ customers are starting the process backup as JF mentioned and our plant is now back up and running since the 22 or 23 of this month. So, we’re are starting to see that process of restarting plants, but they are not all up and running at this particular stage, but again, as we look at our sales of Zircon in the first quarter, Q4 to Q3 – I mean Q3 to Q4 in 2019, we were up 7% and we’re seeing numbers that are very similar to that in Q1.

Not up 7%, but in line with Q4.

Got it. Thank you very much.

Our next question comes from Brian Lalli with Barclays.

Hi, guys. Good morning. Maybe first just on a housekeeping item on the EBITDA outlook and synergies, I just want to make sure we’re thinking about this correctly on a year-over-year basis, if I and correct me if I’m wrong of any of these, but if I take [$681 million] of pro forma EBITDA and then you add the, you know, $22 million of basically future savings that were, you know, realized and enacted in 2019, is that a right starting point that we would then have the $100 million improvement on from the synergy basis? I appreciate that maybe that $190 million doesn’t – you know doesn’t have all that in the EBITDA number specifically, and, you know, again I know there a lot of pieces moving around furnace relines, Zircon pricing, that's – would love to maybe summarize some of the key puts and takes on the $700 million to $800 million outlook if that's possible, and then I have a follow-up, thanks.

Hi, Brian. It’s Tim. The components of the EBITDA in 2019, we had $47 million that hit our EBITDA line. We had another $22 million associated with synergies in our pigment plants and our mineral sands operations that capitalized inventory and the remaining $20 million is interest and taxes and some miscellaneous items. That $22 million in the synergies we relate – we realize in our pigment plants and our mineral sands operations, they roll into the P&L in the pigment plants in two to three months and they roll through mineral sands in the pigment plants in a matter of probably five or six months. So there’s always going to be a component as we flow through the year that’s going to be onto the balance in terms of incremental synergies, but I would expect that to – that $22 million to decline [a tad] in 2020 and increase again in 2021 as we ramp some additional synergy items. On the bottom of that page, we’ve actually tried to identify for the investors, the amount of EBITDA that we’re actually expecting to achieve in our calendar year for the P&L and you can see that’s $140 million in 2020.

Got it. That’s – I appreciate that. I actually missed the bottom one, so I apologize.

No worry.

And then, Tim, maybe just as a follow up, you know, again, I appreciate the comments on priorities for capital allocation and continued debt repayment. You know, is it fair are you still thinking about the $2.5 billion gross debt as the target? So, you know, basically another, you know, $500 million of debt reduction sort of in front of us over the next two years given that the 2021 target is, is that the right way to think about it?

Absolutely, Brian.

Okay, great. And I appreciate the confirmation, thanks guys.

Thank you.

Our next question comes from Jeff Zekauskas of JPMorgan.

Thanks very much. You may have answered this, in 2020, when you extract an incremental, you know, I don't know, $90 million cost savings or $100 million on a run rate basis, how much will that cost you and how much will it cost you incrementally versus 2019? I mean, what are the cash outlays? That's what I mean by cost.

Yes. The cash outlays as it relates to SG&A in some of the miscellaneous synergies will be pretty much flat year-on-year and the capital needed to achieve those synergies are within the $275 million that we’ve outlined.

Right. And so, how much capital will be spent on that in 2020?

My guess JF correct me if I’m wrong, of the $275 million maybe $15 million to $20 million.

Yes, that’s a good number, yes. And what happens, Jeff, obviously is a lot of the SG&A synergies that are – you are able to deliver early have cash cost, but some of the things in best practices and some of those things that we’re now starting to see impact for really don't have a significant cash cost, but you start to get more and more benefit from those as you move forward.

Okay. And then lastly, are you seeing any new China chloride-based TiO2 coming into the global markets?

There has been nothing more than what has already been announced. I mean, obviously, there is companies that are continuing to work on perfecting that technology, including [indiscernible], but there's been no significant announcements in China recently.

Do you feel it in the market? That is, is it being shipped at higher rates in some market?

No, quite honestly we don't.

Okay, great. Thank you so much.

Thanks Jeff.

And I’m not showing any further questions at this time. I would now like to turn the call back to Jeff Quinn for closing remarks.

Thank you. Well, I just want to thank you for your time today. We are optimistic on the outlook for the TiO2 sector as we move forward. We continue to focus on execution of the things that we can control and we continue to be very focused on delivering industry leading financial performance irrespective of whatever the macro economic conditions we face. And thank you very much and we look forward to talking to you on our first quarter call in a few months.

Ladies and gentlemen, this does conclude today’s presentation. You may now disconnect and have a wonderful day.